The μ-opioid receptor down-regulates differently from the δ-opioid receptor: Requirement of a high affinity receptor/G protein complex formation

Molecular Pharmacology

Volumn 52, Issue 1, 1997, Pages 105-113

  Chakrabarti, Sumita ^a,b   Yang, Wanling ^a   Law, Ping Yee ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; PERTUSSIS TOXIN;

AMINO ACID METABOLISM; AMINO ACID SEQUENCE; ARTICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 0030742024     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.1.105     Document Type: Article

References (40)

1. Pasternak, G. W. The Opiate Receptors. The Humana Press, Clifton, NJ (1988).
2. Gilbert, P. E., and W. R. Martin. The effects of morphine- and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198:66-82 (1976).
3. Goldstein, A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol. Sci. 8:456-459 (1987).
4. Corbett, A. D., S. J. Paterson, and H. W. Kosterlitz. Selectivity of ligands for opioid receptors, in Opioids I (A. Herz, ed.). Springer-Verlag, Berlin, 645-679 (1993).
5. Evans, C. J., D. J. Keith, H. Morrison, K. Magendzo, and K. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science (Washington D. C.) 258:1952-1955 (1992).
6. Keiffer, B. L., K. Befort, R. C. Gaveriaux, and C. G. Hirth. The 8 opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci USA 89:12048-12052 (1992).
7. Chen, Y., A. Mestek, J. Liu, J. A. Hurley, and L. Yu. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:8-12 (1993).
8. Yasuda, K., K. Raynor, H. Kong, C. D. Breder, J. Takeda, T. Reisine, and G. I. Bell. Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc Natl. Acad. Sci. USA 90:6736-6740 (1993).
9. Thompson, R. C., A. Mansour, H. Akil, and S. J. Watson. Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11: 903-913 (1993).
10. Minami, M., T. Takashi, Y. Katao, K. Maekawa, S. Nakamura, T. Onogi, S. Kaneko, and M. Satoh. Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329:291-295 (1993).
11. Minami, M., and M. Satoh. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23:121-145 (1995).
12. Raynor, K., H. Kong, Y. Chen, K. Yasuda, L. Yu, G. I. Bell, and T. Reisine. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:330-334 (1994).
13. Law, P. Y., T. M. McGinn, M. J. Wick, L. J. Erickson, C. J. Evans, and H. H. Loh. Analysis of delta opioid receptor activities expressed in CHO cell lines: function of receptor density? J. Pharmacol. Exp. Ther. 271:1686-1694 (1994).
14. 2A cells stably expressing a cloned μ-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Mol. Brain Res. 30:269-278 (1995).
15. Law, P. Y., D. S. Hom, and H. H. Loh. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. Mol. Pharmacol. 22:1-4 (1982).
16. i in ND8-47 neuroblastoma X dorsal root ganglion hybrid cells is mediated through G-protein-coupled delta-opioid receptors and desensitized by chronic exposure to opioid. J. Neurochem. 65:1612-1621 (1995).
17. Chang K.-J., R. W. Eckel, and S. G. Blanchard. Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature (Lond.) 296:446-448 (1982).
18. Law, P. Y., D. S. Hom, and H. H. Loh. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24:413-424 (1983).
19. Zadina, J. E., S. L. Chang, L. J. Ge, and A. J. Kastin. Mu opiate receptor down-regulation by morphine and upregulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:254-262 (1993).
20. Carter, B. D., and F. Medzihradsky. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43:465-473 (1993).
21. Prather, P. L., A. W. Tsai, and P. Y. Law. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. J. Pharmacol. Exp. Ther. 270:177-184 (1994).
22. Law, P. Y., D. S. Hom, and H. H. Loh. Down-regulation of opiate receptor in neuroblastoma X glioma NG108-15 hybrid cells: chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259:4096-4104 (1984).
23. Law, P. Y., A. K. Louie, and H. H. Loh. Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma X glioma NG108-15 hybrid cells. J. Biol. Chem. 260:14818-14823, (1985).
24. 5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma X glioma NG108-15 hybrid cells. J. Pharmacol. Exp. Ther. 256:710-716 (1991).
25. Kong, H., K. Raynor, K. Yasuda, S. T. Moe, P. S. Portughese, G. I. Bell, and T. Reisine. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:23055-23058 (1993).
26. Surratt, C. K., P. S. Johnson, A. Moriwaki, B. K. Seidleck, C. J. Blaschak, J. B. Wang, and G. R. Uhl. μ-opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:20548-20553 (1994).
27. Chen, C., and H. Okayama. Calcium phosphate-mediated gene transfer: a high efficient transfection system for stable transforming cells with plasmid DNA. Mol. Cell Biol. 7:2745-2752 (1987).
28. Law, P. Y., D. S. Hom, and H. H. Loh. Opiate regulation of adenosine 3′,5′-cyclic monophosphate levels in neuroblastoma X glioma NG108-15 cells: relationship between receptor occupancy and effect. Mol. Pharmacol. 23:26-35 (1983).
29. White, A. A., and D. B. Karr. Improved two-step method for the assay of adenylate and guanylate cyclase. Anal. Biochem. 85:451-460 (1978).
30. 32P]GTP labeling of multiple G protein α-subunits. J. Neurochem. 64:2534-2543 (1995).
31. Roerig, S. C., H. H. Loh, and P. Y. Law. Identification of three separate guanine nucleotide-binding proteins that interact with the δ-opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells. Mol. Pharmacol. 41:822-831 (1992).
32. Fraser, C. M., F-Z. Chung, C-D. Wang, and J. C. Venter. Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. Proc. Natl. Acad. Sci. USA 85:5478-5482 (1988).
33. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science (Washington D. C.) 257:977-980 (1992).
34. Blume, A. J. Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proc. Natl. Acad. Sci. USA 75:1713-1717 (1978).
35. Chang, K. J., E. Hazum, A. Killan, and P. Cutrecasas. Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. Mol. Pharmacol. 20:1-7 (1981).
36. Costa, T., F. J. Klinz, L. Vachon, and A. Herz. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Mol. Pharmacol. 34:744-754 (1988).
37. Law, P. Y., D. S. Hom, and H. H. Loh. Multiple affinity states of opiate receptor in neuroblastoma X glioma NG108-15 cells: opiate agonist association rate is a function of receptor occupancy. J. Biol. Chem. 260:3561-3569 (1985).
38. Costa, T., M. Wuster, C. Gramsch, and A. Herz. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells. Mol. Pharmacol. 28:146-154 (1985).
39. DeLean, A., J. M. Stadel, and R. J. Lefkowitz. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 255:7108-7117 (1980).
40. s. Mol. Pharmacol. 34:132-138 (1988).